IZGREV
150MG/12,5MG TBL FLM 30
| SÚKL code | 0248730 |
|---|---|
| Name of the product | IZGREV |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | IZGREV |
| Supplement | 150MG/12,5MG TBL FLM 30 |
| Strenght | 150MG/12,5MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 30 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance |
HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDUM) IRBESARTAN (IRBESARTANUM) |
| ATC group | C09DA04 |
| ATC group name | IRBESARTAN A DIURETIKA |
| Doping | Diuretika a maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz www.antidoping.cz/cs/zakazane-leky |
Marketing authorisation information
| Registration Number | 58/ 179/20-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Reference member state |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Swyssi AG, Frankfurt am Main |
| MA Holder country | NĚMECKO |
cz